Client Story: NASA
“The outcomes of the popup accelerator were above and beyond my expectations. As part of the pharmaceutical industry, which is very conservative and heavily regulated, we had our doubts regarding the potential outcomes of an internal innovation process. We are now deep into the process with outcomes in the form of clearly defined opportunities to impact our strategic KPI’s through employee-driven innovation ventures. It is our intention to adopt several of the ventures as part of our official work plans. In addition, this process has proven how far our employees can go in terms of their creativity, persistence, and willingness to promote the company’s goals through personal initiative and innovation, which to me was the most gratifying aspect of the whole process.”
About the customer:
AstraZeneca is a British-Swedish company. among the world’s largest pharmaceutical and biopharmaceutical companies. Has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
About the project and the challenges:
The goal was to harness the creativity and the inner-drive of the organization’s employees in Israel with the intention of providing greater value to customers, patients and healthcare providers.
The results of the process:
Even though the intention was to choose three initiatives that will go on to the next level and start experimenting, the management team choice was to give the green light to four initiatives due to the quality level of the initiatives presented. In addition, a decision was made to execute an additional popup accelerator the following year.